Prescription drug · ANDA
Carbidopa and Levodopa NDC 55154-0192
Carbidopa hydrate 25 mg/1; Levodopa 250 mg/1 · Tablet · Oral · Cardinal Health 107, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55154-0192-0 | 5515401920055154019200 | 10 BLISTER PACK in 1 BAG (55154-0192-0) / 1 TABLET in 1 BLISTER PACKMarketed from Oct 10, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbidopa and Levodopa
- Generic name (nonproprietary)
- carbidopa and levodopa
- Active ingredients
- Carbidopa hydrate — 25 mg/1Levodopa — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Cardinal Health 107, LLCNDC labeler code 55154
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 073607
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 55154-0192_1eaa3310-3185-42fb-83f4-6e44b32f61c0SPL ID 1eaa3310-3185-42fb-83f4-6e44b32f61c0SPL set ID 19d853e2-b8bd-490e-b8d2-b38bec68a139RxCUI 197444, 197445UNII MNX7R8C5VO, 46627O600JUPC 0055154264303
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455154019200followed by a unit qualifier and the quantityPackage 55154-0192-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Carbidopa and levodopa tablets, USP are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbi…
Excerpt only. Read the full label for complete information.
About NDC 55154-0192
- What is NDC 55154-0192?
- 55154-0192 is the product NDC for Carbidopa and Levodopa, Carbidopa hydrate 25 mg/1; Levodopa 250 mg/1 tablet, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Carbidopa and Levodopa.
- What is the active ingredient?
- Carbidopa hydrate, Levodopa.
- Who is the labeler?
- Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Carbidopa and Levodopa?
- 97 other product NDCs are listed under this name. See all Carbidopa and Levodopa NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Carbidopa and Levodopa products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Coupler LLC | 67046-1689 | 67046-1689-03 |
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | AvPAK | 50268-202 | 50268-0202-15 |
| Carbidopa and Levodopa | Carbidopa 48.75 mg/1; Levodopa 195 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4621 | 70518-4621-00 |
| Carbidopa and Levodopa | Carbidopa 23.75 mg/1; Levodopa 95 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4618 | 70518-4618-00 |
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4620 | 70518-4620-00 |
| Carbidopa and Levodopa | Carbidopa 36.25 mg/1; Levodopa 145 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4630 | 70518-4630-00 |
| Carbidopa and Levodopa | Carbidopa 61.25 mg/1; Levodopa 245 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4610 | 70518-4610-00 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Coupler LLC | 67046-1668 | 67046-1668-03 |
| Carbidopa and Levodopa | Carbidopa hydrate 25 mg/1; Levodopa 100 mg/1 | Tablet, Extended releaseOral | Safecor Health, LLC | 48433-015 | 48433-0015-20 |
| Carbidopa and Levodopa | Carbidopa hydrate 50 mg/1; Levodopa 200 mg/1 | Tablet, Extended releaseOral | Safecor Health, LLC | 48433-016 | 48433-0016-20 |
Other NDCs under ANDA 073607
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8516 |
| Carbidopa and Levodopa | Carbidopa hydrate 25 mg/1; Levodopa 250 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7549 |
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Dr. Reddy's Laboratories Inc | 75907-021 |